Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
Eli Lilly and Company
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
AHS Cancer Control Alberta
Mayo Clinic